Keyphrases
Cannabinoid Receptor 1 (CB1R)
100%
Cardiac Fibrosis
100%
Left Ventricular Hypertrophy
100%
Uremia
100%
CB1 Receptor
100%
Cannabinoid Receptor Antagonists
100%
CB1R Antagonist
38%
Indoxyl Sulfate
38%
H9c2 Cells
30%
Uremic Cardiomyopathy
30%
Chronic Kidney Disease
23%
Myocardial Fibrosis
23%
Transforming Growth Factor-β
15%
Akt Phosphorylation
15%
AKT Pathway
15%
Collagen I
15%
α-smooth muscle Actin (α-SMA)
15%
Uremic Toxins
15%
Therapeutic Potential
7%
Knockdown
7%
Drug Target
7%
Expression Level
7%
Mouse Model
7%
Signaling Pathway
7%
Immunohistochemical Staining
7%
Small Interfering RNA (siRNA)
7%
Dose Effect
7%
Immunoblotting
7%
Echocardiography
7%
Antifibrotic
7%
Marker Expression
7%
Myofibroblast
7%
RNA-based
7%
Pathological Features
7%
Fibrotic Markers
7%
H9c2
7%
Heart Size
7%
Fibrosis Marker
7%
OAT1
7%
5/6 Nephrectomy
7%
Myocardial Hypertrophy
7%
Medicine and Dentistry
Cannabinoid 1 Receptor Antagonist
100%
Indican
100%
Cardiac Fibrosis
100%
Left Ventricular Hypertrophy
100%
Experimental Uremia
100%
Myocardial Disease
80%
Chronic Kidney Disease
60%
Akt Signaling
40%
Uremic Toxin
40%
Smooth Muscle Actin
40%
Cancer Growth Factor
40%
Upregulation
20%
Fibrosis
20%
Drug Delivery System
20%
Myofibroblast
20%
Signal Transduction
20%
Small Interfering RNA
20%
Echocardiography
20%
Immunoblotting
20%
Ventricular Hypertrophy
20%
Nephrectomy
20%
Organic Anion Transporter 1
20%
Cannabinoid Receptor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid 1 Receptor Antagonist
100%
Indican
100%
Heart Muscle Fibrosis
100%
Heart Left Ventricle Hypertrophy
100%
Experimental Uremia
100%
Myocardial Disease
80%
Chronic Kidney Failure
60%
Uremic Toxin
40%
Smooth Muscle Actin
40%
Cancer Growth Factor
40%
Western Blot
20%
Drug Delivery System
20%
Mouse Model
20%
Small Interfering RNA
20%
Fibrosis
20%
Heart Ventricle Hypertrophy
20%
Organic Anion Transporter 1
20%
Cannabinoid Receptor
20%